Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Under this agreement Apollo Healthcare will provide its Prior-Authorization package, amongst other services to ART’s existing customer base, as well as any healthcare facilities considering use of their products such as PreciseRT and AccuBoost for adoption within their clinical patient treatment armamentariums.
News | Radiation Therapy
Advanced Radiation Therapy, LLC and Apollo Healthcare Announce Strategic Partnership

October 21, 2021 — Advanced Radiation Therapy, LLC (ART) and Apollo Healthcare have announced a strategic partnership ...

Time October 21, 2021
arrow
IBA announced the launch of the world’s first online platform dedicated to proton therapy. The new interactive platform called Campus was unveiled through a series of webinars on October 19-20, 2021. It will also be showcased at the American Society for Radiation Oncology (ASTRO) Annual Meeting
News | Proton Therapy
IBA Launches the World’s First Online Proton Therapy Platform

October 20, 2021 — IBA (Ion Beam Applications SA), the world leader in particle accelerator technology and the world’s ...

Time October 20, 2021
arrow
RefleXion is developing biology-guided radiotherapy* (BgRT), which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT).
News | Radiation Oncology
RefleXion Announces Newly Formed Scientific Advisory Board

October 20, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) as a ...

Time October 20, 2021
arrow
RAD Technology Medical Systems provides complex, design-built modular facilities for the healthcare industry. #ASTRO #ASTRO21
News | Radiation Therapy
RAD Technology Medical Systems to Exhibit at the ASTRO 2021

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

Time October 19, 2021
arrow
Sun Nuclear's SunCHECK Platform enables comprehensive remote quality assurance (QA) for radiation therapy, during COVID-19 and beyond.
News | Quality Assurance (QA)
ITN Launches New Comparison Chart on Radiation Therapy QA

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
NBTXR3 is a novel, potentially first-in-class oncology product composed of functionalized hafnium oxide nanoparticles that is administered via one-time intratumoral injection and activated by radiotherapy.
News | Radiation Therapy
NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program at ASTRO21

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility. ViewRay will be exhibiting at the annual ASTRO 2021 conference
News | Radiation Therapy
ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
Sun Nuclear’s SunCHECK Patient QA uses calibrated EPID data to enable true dosimetric in-vivo monitoring, creating a fully independent absolute dosimetric QA of patient treatments.
Feature | Radiation Therapy | By Dave Fornell
The Importance of Radiation Oncology Quality Assurance Systems for Safe and Accurate Treatment Delivery

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline).
Feature | Radiation Therapy
Radiation Therapy Reprograms Heart Cells to Younger State

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%
News | Radiation Oncology
Global $5.8 Billion Radiotherapy Devices 2021 Market Report

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.
News | Prostate Cancer
Metastatic Prostate Cancer Comes in Two Forms, Which Could Guide Treatment

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report
News | Radiation Therapy
Surface Guided Radiation Therapy Market Outlook

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.
News | Lung Imaging
$3M Grant Establishes Center to Combat Racial Inequities in Lung Cancer

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.
News | Radiation Oncology
New Research Guidelines Will Boost Interventional Oncology Research

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  
News | Radiation Oncology
Research Shows a Struggle to Keep Up With the Pace of Change in Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and commercialization collaboration to evaluate the use of piflufolastat F 18, Lantheus’ prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agent, to enable real-time therapeutic guidance of biology-guided radiotherapy (BgRT) in prostate cancer using the RefleXion X1 platform. 
News | PET Imaging
Lantheus and RefleXion Announce Collaboration with Potential to Improve Future Prostate Cancer Treatment

September 13, 2021 — Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and ...

Time September 13, 2021
arrow
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus
News | Radiation Oncology
Oncology Research Rebounds from Pandemic Low, But Shows Cancer Patients Need Attention After COVID-19 Recovery

September 13, 2021 — At the opening press conference of the ESMO Congress 2021, President Solange Peters announced that ...

Time September 13, 2021
arrow
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments
News | ASTRO
ASTRO Submits RO Model Comment Letters to CMS

September 9, 2021 — The American Society for Radiation Oncology (ASTRO) submitted two comment letters to the Centers for ...

Time September 09, 2021
arrow
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA)
Sun Nuclear Highlights Expanded Machine QA Capabilities

September 2, 2021 — At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive ...

Time September 02, 2021
arrow
Featured in the ESTRO scientific program, three members of the Sun Nuclear SunCHECK Platform Customer Advisory Board will present on breakthrough findings from their use of SunCHECK software for independent, automated Machine QA and Patient QA, featuring in-vivo dosimetry.
News | Quality Assurance (QA)
Multi-Year Studies from Sun Nuclear’s SunCHECK Platform Customer Advisory Board Presented at ESTRO 2021

September 1, 2021 — Sun Nuclear Corporation announced that as part of the ESTRO 2021 Congress, held August 27 – 31 in ...

Time September 01, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now